Apollo Hospitals logo

Apollo Hospitals

APOLLOHOSP NSE

Key Fundamentals

LargecapHospitalsHealthcare Services
Market Cap
1.1L Cr
Volatility
Moderate
P/E Ratio
55.97
EBITDA
₹3,961 Cr
Return on Equity
20.08%
Debt to Equity
0.9
Book Value
₹659.33
EPS
₹72.05
52W High
₹9,070.5
52W Low
₹6,696.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has delivered good profit growth of 76.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 17.7%

Weaknesses

2
  • Stock is trading at 12.3 times its book value
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
15.58% higher than 3Y
Net Income Growth
33.06% higher than 3Y
Cash Flow Change
33.67% lower than 3Y
ROE
15.47% lower than 3Y
ROCE
27.43% lower than 3Y
EBITDA Margin (Avg.)
6.35% lower than 3Y

AI Analysis — Bull vs Bear

6d ago
AI opinion · based on fundamentals
Risk medium

Apollo Hospitals Enterprise Ltd has a market capitalisation of about ₹1,28,047 crore. Its profits have grown at a 76% CAGR over five years and 34% over the trailing twelve months, on sales growth of 19% and 17% over the same periods. Return on equity has risen from a 10-year average of 13% to 21% last year. The stock trades at 58.9 times earnings and 13.5 times book value, with a dividend yield of 0.23%.

Bull Case 7
  • Profits have compounded at 76% CAGR over 5 years, 32% over 3 years and 34% over the trailing twelve months, so growth has stayed high over more than one timeframe.
  • Sales growth has been steady: 15% over 10 years, 19% over 5 years, 15% over 3 years and 17% TTM. This points to consistent demand for the company's services.
  • Return on equity has improved steadily, from a 13% 10-year average to 17% over 5 years, 18% over 3 years and 21% last year. This suggests the company is earning more on its capital.
  • TTM profits grew 34%, about twice the 17% sales growth. That gap points to operating leverage and wider margins as the business grows.
  • The stock has compounded at 21% over 10 years, 20% over 3 years and 18% over the past year, a long record of returns to shareholders.
  • The dividend payout ratio is 17.7%, so the company pays shareholders while keeping over 80% of earnings to reinvest in growth.
  • With a market capitalisation of about ₹1,28,047 crore, Apollo is one of the largest listed healthcare services companies in India. Its size helps with bargaining power, brand recognition and access to capital.
Bear Case 8
  • A P/E of 58.9 means an earnings yield of only about 1.7%. The price already assumes strong growth will continue, so any slowdown could hit the stock hard.
  • A price-to-book ratio of 13.5 is high even for an asset-heavy hospital business. It leaves little room if returns on equity fall back from last year's 21%.
  • The company may be capitalising interest costs. If so, interest is added to asset values instead of being charged as an expense, which can make reported profits look higher and hide the true cost of expansion.
  • The 76% 5-year profit CAGR is inflated by a low starting point during the pandemic. The 10-year profit CAGR of 23% is a more normal guide, and it is well below what the 5-year figure suggests.
  • The 10-year average ROE is only 13%, which shows returns have been weak during past heavy-investment phases. Returns could weaken again if new bed capacity takes time to fill.
  • Sales growth has slowed from 19% over 5 years to 15% over 3 years. That makes it harder to keep profit growth well ahead of revenue.
  • The stock's 5-year CAGR of 14% trails its 10-year CAGR of 21% and falls far short of the 76% profit growth over the same period. This shows valuation multiples have already shrunk, and fast profit growth has not always turned into matching share-price gains.
  • The dividend yield is only 0.23%, so investors earn very little income and depend almost entirely on share-price gains.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago
Neutral 1
  • ₹61.75 crore block trade flagged Sep 30

    A trade-scanning system flagged about 75,279 Apollo Hospitals shares worth ₹61.75 crore on BSE at ₹8,202.95 per share. This signal has not been confirmed by the exchange, and the buyer and seller will only be known after the post-market disclosure.

TL;DR: The only news item is an unconfirmed large-trade signal of about ₹61.75 crore at ₹8,202.95 per share on Sep 30. It doesn't tell us whether this was buying or selling. Trades of this size are common in large-cap stocks and often reflect institutional rebalancing rather than a change in fundamentals. The news flow points to no clear bullish or bearish trend. The exchange's post-market bulk/block deal disclosure, which would identify the parties involved, is the next thing to watch.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,418
4,847
4,851
4,944
5,086
5,589
5,527
5,592
5,842
6,304
6,477
6,606
7,044
Expenses
3,909
4,219
4,237
4,303
4,410
4,774
4,765
4,822
4,990
5,362
5,512
5,594
5,951
Operating Profit
509
628
614
640
675
816
762
770
852
941
965
1,011
1,092
OPM %
12%
13%
13%
13%
13%
15%
14%
14%
15%
15%
15%
15%
16%
Other Income
34
26
29
37
49
44
69
72
54
61
48
54
62
Interest
106
111
113
119
116
118
110
115
108
110
113
119
120
Depreciation
167
163
167
190
177
184
185
211
215
218
219
224
235
PBT
270
379
363
368
430
557
536
516
583
675
682
722
799
Tax %
36%
34%
30%
30%
27%
29%
29%
20%
24%
27%
24%
24%
24%
Net Profit
173
249
254
258
316
396
379
414
441
494
516
551
610
EPS in Rs
11.59
16.2
17.06
17.65
21.23
26.34
25.89
27.1
30.1
33.19
34.93
36.81
40.39
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5,129
6,150
7,256
8,243
9,617
11,247
10,560
14,663
16,612
19,059
21,794
25,228
26,430
Expenses
4,392
5,465
6,522
7,442
8,548
9,656
9,420
12,474
14,548
16,665
18,761
21,449
22,420
Operating Profit
737
684
734
801
1,070
1,591
1,140
2,189
2,065
2,394
3,033
3,779
4,010
OPM %
14%
11%
10%
10%
11%
14%
11%
15%
12%
13%
14%
15%
15%
Other Income
47
92
60
24
26
222
103
368
75
123
222
207
226
Interest
118
180
257
295
327
533
449
379
381
449
458
450
462
Depreciation
212
264
314
359
396
620
573
601
615
687
758
876
896
PBT
455
332
222
171
373
660
221
1,578
1,144
1,380
2,039
2,661
2,877
Tax %
29%
29%
41%
65%
47%
34%
38%
30%
22%
32%
26%
25%
—
Net Profit
335
235
131
60
200
432
137
1,108
844
935
1,505
2,003
2,172
EPS in Rs
24.43
16.99
15.88
8.44
16.96
32.7
10.46
73.42
56.97
62.5
101
135
145
Div. Payout %
24%
35%
38%
59%
35%
18%
29%
16%
26%
26%
13%
15%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
70
70
70
70
70
70
72
72
72
72
72
72
Reserves
3,102
3,262
3,244
3,182
3,264
3,270
4,531
5,551
6,126
6,864
8,140
9,408
Borrowings
1,992
2,834
3,125
3,427
3,673
3,596
4,160
4,068
4,332
5,333
7,864
8,493
Other Liabilities
1,296
1,195
1,665
1,917
2,159
4,354
2,629
3,570
3,886
4,474
4,568
4,210
Total Liabilities
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Fixed Assets
3,244
3,997
4,591
4,773
4,982
7,432
6,778
8,296
8,520
9,664
10,988
12,272
CWIP
533
562
347
712
822
236
234
46
610
873
921
1,032
Investments
311
352
406
352
462
434
1,343
816
574
986
2,487
2,179
Other Assets
2,372
2,448
2,759
2,759
2,901
3,187
3,037
4,104
4,712
5,219
6,248
6,700
Total Assets
6,459
7,360
8,103
8,596
9,166
11,289
11,392
13,261
14,416
16,742
20,644
22,183
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
470
597
623
537
905
1,293
1,265
1,696
1,377
1,920
2,136
2,856
Investing
-759
-888
-1,152
-405
-711
-289
-880
-747
-857
-1,537
-3,383
-2,145
Financing
392
330
477
-108
-215
-910
-340
-792
-633
-311
1,319
-478
Net Cash Flow
103
39
-52
24
-20
94
44
158
-113
72
73
233
Free Cash Flow
-396
-393
-46
-84
233
782
984
1,044
252
785
439
925
CFO/OP
77
108
103
83
103
100
108
87
85
100
86
92
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
43
36
38
37
39
33
46
44
49
48
51
50
Inventory Days
50
49
47
51
46
49
16
21
17
17
16
15
Days Payable
59
66
51
55
56
60
74
79
82
88
72
63
Cash Conversion Cycle
34
19
34
33
29
22
-12
-14
-16
-23
-6
3
Working Capital Days
24
16
27
8
-3
-8
-4
5
-1
-19
-6
-25
ROCE %
12%
9%
8%
7%
10%
14%
8%
17%
14%
15%
17%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Apollo Hospitals insights

64 extracted metrics + investor summaries across FY00–FY27.

Log in — free

Shareholding Pattern

Others2.05%Govt.0.23%FIIs41.50%Public4.48%DIIs23.72%Promot.28.02%As ofJun 2026
2.49% of promoter holding pledged as of Jun 2026

Documents

Frequently Asked Questions about Apollo Hospitals

What does Apollo Hospitals Enterprise Ltd do?
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremo...
Where is Apollo Hospitals Enterprise Ltd (APOLLOHOSP) listed?
Apollo Hospitals Enterprise Ltd trades as APOLLOHOSP on the NSE and under code 508869 on the BSE.
Which sector does Apollo Hospitals Enterprise Ltd belong to?
Apollo Hospitals Enterprise Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd has a market capitalisation of ₹1,14,877 Cr, which places it in the Large Cap band.
What is the PE ratio of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd trades at a PE ratio of 55.97, on earnings per share of ₹72.05, against a book value of ₹659.33 per share.
What is the 52-week high and low of Apollo Hospitals Enterprise Ltd?
Over the last 52 weeks Apollo Hospitals Enterprise Ltd has traded between ₹6,696.5 and ₹9,070.5.
Does Apollo Hospitals Enterprise Ltd pay dividends?
Apollo Hospitals Enterprise Ltd has a dividend yield of 0.24%.
What is the Return on Equity (ROE) of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd reported a return on equity of 20.08%. Its debt-to-equity ratio is 0.90.

Company Information

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Website apollohospitals.com
CEO Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS
Employees 42,497
Listed 1996-01-10
Face Value ₹ 5
Issued Size 14,37,84,657

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/APOLLOHOSP.md for Apollo Hospitals Enterprise Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare Services → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List